International Journal of Blood Transfusion

International Journal of Blood Transfusion

International Journal of Blood Transfusion – Aim And Scope

Open Access & Peer-Reviewed

Submit Manuscript

Aims & Scope

International Journal of Blood Transfusion (IJBT) publishes rigorous research advancing transfusion medicine, blood banking, hematology, and cellular therapy. We focus on blood safety, component preparation, transfusion immunology, and clinical applications across surgical, oncological, and critical care settings.

Transfusion Medicine Blood Banking Hematology Cellular Therapy Blood Safety Immunohematology

Core Research Domains

💉

Transfusion Medicine & Blood Banking

  • Blood donor recruitment, retention, and health monitoring
  • Blood component preparation (RBCs, platelets, plasma, cryoprecipitate)
  • Blood product storage, testing, and quality assurance
  • Transfusion-transmitted infection prevention and detection
  • Adverse transfusion reaction management and hemovigilance
  • Blood inventory management and distribution logistics
Typical Fit Example

"Comparative analysis of pathogen reduction technologies for platelet concentrates: impact on bacterial contamination rates and post-transfusion platelet recovery in thrombocytopenic patients."

🔬

Transfusion Immunology & Compatibility

  • Red cell alloimmunization and antibody identification
  • HLA alloimmunization and platelet refractoriness
  • Transfusion-related acute lung injury (TRALI) mechanisms
  • Hemolytic transfusion reactions (acute and delayed)
  • Immunological assays for blood group serology
  • Transfusion-associated graft-versus-host disease (TA-GVHD)
Typical Fit Example

"Incidence and risk factors for red cell alloimmunization in multiply-transfused sickle cell disease patients: a 10-year retrospective cohort study with extended phenotype matching protocols."

💊

Hematologic Disorders & Blood Diseases

  • Anemia (hemolytic, aplastic, autoimmune, nutritional)
  • Hemoglobinopathies (sickle cell disease, thalassemia)
  • Coagulation disorders (hemophilia, von Willebrand disease)
  • Thrombotic disorders and thrombophilia
  • Hematologic malignancies (leukemia, lymphoma, myeloma)
  • Bone marrow failure syndromes
Typical Fit Example

"Transfusion burden and iron overload in beta-thalassemia major: efficacy of chelation therapy and impact on cardiac function assessed by T2* MRI in a multi-center cohort."

📈

Cellular Therapy & Apheresis

  • Hematopoietic stem cell transplantation (autologous and allogeneic)
  • Therapeutic apheresis (plasmapheresis, cytapheresis)
  • Stem cell mobilization and collection techniques
  • Graft processing and cryopreservation
  • Donor selection and HLA matching strategies
  • Post-transplant transfusion support and complications
Typical Fit Example

"Optimization of peripheral blood stem cell collection in poor mobilizers: comparison of plerixafor timing protocols and impact on CD34+ cell yield and subsequent engraftment kinetics."

Secondary Focus Areas

Clinical Transfusion Practice

  • Massive transfusion protocols in trauma and surgery
  • Transfusion strategies in oncology and hematology
  • Neonatal and pediatric transfusion medicine
  • Patient blood management programs
  • Transfusion in critical care and emergency settings

Laboratory Methods & Diagnostics

  • Blood group genotyping and molecular typing
  • Coagulation testing and hemostasis monitoring
  • Flow cytometry in hematology diagnostics
  • Quality control and proficiency testing
  • Point-of-care testing in transfusion medicine

Regulatory & Policy

  • Blood safety regulations and compliance
  • Transfusion service accreditation standards
  • Hemovigilance systems and adverse event reporting
  • Ethical considerations in blood donation
  • Global blood supply and access disparities

Education & Training

  • Transfusion medicine curriculum development
  • Competency assessment in blood banking
  • Simulation-based training programs
  • Continuing professional development
  • Patient education on transfusion therapy

Emerging Research Frontiers

💡

Selective Consideration Areas

Artificial Intelligence & Machine Learning

AI applications in donor-recipient matching, transfusion reaction prediction, blood inventory optimization, and automated blood group typing systems.

Gene & Cell Therapy

Gene editing for hemoglobinopathies, CAR-T cell therapy support, and novel cellular therapeutics requiring transfusion medicine expertise.

Blood Substitutes & Alternatives

Hemoglobin-based oxygen carriers, synthetic platelets, cultured red blood cells, and other blood component alternatives in development.

Precision Transfusion Medicine

Pharmacogenomics of transfusion responses, personalized transfusion thresholds, and biomarker-guided transfusion strategies.

⚠ Editorial Note: Manuscripts in these emerging areas undergo additional editorial review to ensure direct relevance to transfusion medicine and hematology. Purely computational or theoretical work without clinical validation may be redirected.

Article Types & Editorial Priorities

Priority 1: Fast-Track

Expedited Review

  • Original Research Articles (2,500-6,000 words)
  • Systematic Reviews & Meta-Analyses
  • Clinical Trials & Randomized Controlled Studies
  • Novel Methodologies in Transfusion Medicine
  • Breakthrough Discoveries in Hematology
Priority 2: Standard Review

Regular Processing

  • Short Communications (1,500-2,500 words)
  • Technical Notes & Laboratory Methods
  • Data Descriptors & Datasets
  • Perspectives & Commentaries
  • Educational Reviews
Priority 3: Selective

Case-by-Case Evaluation

  • Case Reports (exceptional cases only)
  • Opinion Pieces (by invitation)
  • Letters to the Editor
  • Conference Proceedings
  • Book Reviews

Editorial Standards & Requirements

Reporting Guidelines

All manuscripts must follow discipline-specific guidelines: CONSORT (trials), STROBE (observational), PRISMA (reviews), STARD (diagnostics), ARRIVE (animal studies).

💾

Data Availability

Authors must provide data availability statements. Raw data should be deposited in recognized repositories (e.g., Dryad, Figshare, institutional repositories).

📝

Ethics Compliance

Human studies require IRB/ethics committee approval. Animal research must follow institutional IACUC guidelines. Informed consent documentation required.

📄

Preprint Policy

Preprint posting on recognized servers (bioRxiv, medRxiv) is permitted and encouraged. Authors must disclose preprint DOI upon submission.

🔗

Conflicts of Interest

All authors must declare financial and non-financial competing interests. Industry-funded studies require full disclosure of sponsor role in design and analysis.

📜

Clinical Trial Registration

Prospective clinical trials must be registered in recognized databases (ClinicalTrials.gov, ISRCTN, etc.) before patient enrollment begins.

Editorial Performance Metrics

21
Days to First Decision
35%
Acceptance Rate
45
Days to Publication
Open
Access Model

Ready to Submit Your Research?

If your manuscript aligns with our core domains and meets our editorial standards, we invite you to submit. Our editorial team provides constructive feedback to all authors, regardless of decision outcome.

Contact Editorial Office